HSX - Hollywood Stock Exchange. Trade stock in movies, stars and more!
SPIN FACTOR® - The HSX Blog
Box Score: Inception remains firmly planted in first place.
Three new movies underperformed as the sci-fi thriller Inception [INCPT] stayed at the top spot for the third weekend in a row. The heist movie set within dreams hauled in another $27.5 million to bring its cumulative tally to $193.3 million.
Dinner for Schmucks [SHMUC] rang up an estimated $23.3 million to debut in second place. Audience reaction to the comedy was mixed so box office legs could be short with competition from another guy-oriented comedy next weekend.
Holdover pic Salt [ESALT] declined 47% in its second weekend to $19.3 million. The Angelina Jolie [AJOLI] spy thriller has banked $70.8 million thus far. Despicable Me [DESME] grabbed another $15.5 million to push its total to $190.3 million.
Cats & Dogs: The Revenge of Kitty Galore [CTND2] opened in fifth place with $12.5 million. Withh a glut of other 3D options, the sequel came out years too late to retain any goodwill from the first Cats & Dogs.
Charlie St. Cloud [DLCSC] gathered $12.1 million to debut in sixth place. The female fanbase of Zac Efron [ZEFRO] should keep the melodrama afloat during the rest of its run.
| Rank | TITLE | F-S-S | TOTAL |
| 1 | INCEPTION | $27,520,000 | $193,348,000 |
| 2 | DINNER FOR SCHMUCKS | $23,300,000 | $23,300,000 |
| 3 | SALT | $19,250,000 | $70,800,000 |
| 4 | DESPICABLE ME | $15,542,630 | $190,348,825 |
| 5 | CATS & DOGS: THE REVENGE OF KITTY GALORE | $12,525,000 | $12,525,000 |
| 6 | CHARLIE ST. CLOUD | $12,135,870 | $12,135,870 |
| 7 | TOY STORY 3 | $5,035,000 | $389,674,000 |
| 8 | GROWN UPS | $4,500,000 | $150,713,000 |
| 9 | THE SORCERER'S APPRENTICE | $4,320,000 | $51,881,000 |
| 10 | THE TWILIGHT SAGA: ECLIPSE | $3,965,000 | $288,149,954 |
| 11 | RAMONA AND BEEZUS | $3,650,000 | $16,314,691 |
| 12 | THE KIDS ARE ALL RIGHT | $3,463,880 | $9,565,101 |
Source: Exhibitor Relations Co.
Tag(s): INCPT, SHMUC, ESALT, AJOLI, DESME, CTND2, DLCSC, ZEFRO
Recent Comments
| No recent comments. |
